Carboplatin-induced immune hemolytic anemia

Transfusion

Volumn 36, Issue 11-12, 1996, Pages 1016-1018

  Marani, T M ^a   Trich, M B ^a   Armstrong, K S ^a   Ness, P M ^a   Smith, J ^a   Minniti, C ^b   Sandler, S G ^b  

^a AMERICAN RED CROSS BLOOD SERVICES   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CARBOPLATIN; CISPLATIN; COMPLEMENT COMPONENT C3D; ETOPOSIDE; IMMUNOGLOBULIN G ANTIBODY; VINCRISTINE;

ANTIBODY TITER; ARTICLE; ASTROCYTOMA; AUTOIMMUNE HEMOLYTIC ANEMIA; BONE MARROW SUPPRESSION; CASE REPORT; CHILD; COOMBS TEST; DRUG ADSORPTION; HEMAGGLUTINATION; HUMAN; IMMUNE COMPLEX DEPOSITION; INTRAVASCULAR HEMOLYSIS; INTRAVENOUS DRUG ADMINISTRATION; LOW BACK PAIN; MALE;

EID: 0029853198     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1996.36111297091748.x     Document Type: Article

References (7)

1. Garratty G. Drug-induced immune hemolytic anemia. In: Garratty G, ed. Immunobiology of transfusion medicine. New York: Marcel Dekker, 1994:523-51.
2. Walker RH, ed. Technical manual. 11th ed. Arlington: American Association of Blood Banks, 1993:599-675.
3. Cinollo G, Dini G, Franchini E, et al. Positive direct antiglobulin test in a pediatric patient following high-dose cisplatin. Cancer Chemother Pharmacol 1988;21:85-6.
4. Zeger G, Smith L, McQuiston D, Goldfinger D. Cisplatin-induced nonimmunologic adsorption of immunoglobulin by red cells. Transfusion 1988;28:493-5.
5. Getaz EP, Beckley S, Fitzpatrick J, Dozier A. Cisplatin-induced hemolysis. N Engl J Med 1980;302:334-5.
6. Levi JA, Aroney RS, Dalley DN. Haemolytic anaemia after cisplatin treatment. Br Med J (Clin Res Ed) 1981;282:2003-4.
7. Nguyen BV, Jaffe N, Lichtiger B. Cisplatin-induced anemia. Cancer Treat Rep 1981;65:1121.